(Q33866196)

29 July 2017

title

Trends and variations in intravenous vitamin D use among hemodialysis patients in the United States (English)

1 reference

29 July 2017

0 references

1 reference

2

M Alan Brookhart

1 reference

29 July 2017

Anne C Beaubrun

1

1 reference

29 July 2017

Betsy Sleath

series ordinal

3

1 reference

29 July 2017

Lily Wang

series ordinal

4

1 reference

29 July 2017

Abhijit V Kshirsagar

series ordinal

5

1 reference

29 July 2017

publication date

22 October 2012

1 reference

29 July 2017

1 reference

29 July 2017

volume

35

1 reference

29 July 2017

issue

1

1 reference

29 July 2017

page(s)

1-8

1 reference

Impact of race on hyperparathyroidism, mineral disarrays, administered vitamin D mimetic, and survival in hemodialysis patients

29 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5495476

Clinical outcomes with active versus nutritional vitamin D compounds in chronic kidney disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5495476

Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5495476

Vitamin D deficiency and secondary hyperparathyroidism among patients with chronic kidney disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5495476

Doxercalciferol treatment of secondary hyperparathyroidism.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5495476

Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5495476

Vitamin D analogues for the management of secondary hyperparathyroidism.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5495476

Paricalcitol-treated patients experience improved hospitalization outcomes compared with calcitriol-treated patients in real-world clinical settings

5 July 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2012.734260

The survival advantage for haemodialysis patients taking vitamin D is questioned: findings from the Dialysis Outcomes and Practice Patterns Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2012.734260

Effects of monthly dose and regular dosing of intravenous active vitamin D use on mortality among patients undergoing hemodialysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2012.734260

Secondary hyperparathyroidism in chronic hemodialysis patients: prevalence and race

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2012.734260

Trends in intravenous iron use among dialysis patients in the United States (1994-2002).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2012.734260

Race is a major determinant of secondary hyperparathyroidism in uremic patients.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5495476

Meta-analysis: vitamin D compounds in chronic kidney disease

29 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23088380

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Mortality risk among hemodialysis patients receiving different vitamin D analogs

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23088380

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.3109/0886022X.2012.734260

1 reference

29 July 2017

1 reference

29 July 2017

1 reference